We have recently demonstrated an association between the development of both aPL and macrovascular thrombotic events among SLE patients with the HLA-DRB1 alleles and with the polymorphism in the signal transducer and activator of transcription factor 4 (STAT4) gene [12,14]. Here, HLA-DRB1 is linked to systemic lupus erythematosus.